Kuwatsuka, Y <br/><br/>
The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells.  [electronic resource] 

 -  Blood cancer journal  May 2011 
 - e17 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2011.16  doi